MELISSA MCNEIL: Open Payments
NPI 1316455074 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 64 payments from 17 companies in 2025. Trend: 2023 $978 · 2024 $1,230 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $182 |
| ABBVIE INC. | 11 | $144 |
| Novo Nordisk Inc | 8 | $142 |
| GlaxoSmithKline, LLC. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Corcept Therapeutics | 2 | $37 |
Products named: OTEZLA, GEMTESA, TRELEGY ELLIPTA, LEQVIO, UBRELVY, Ozempic, Auvelity, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
